Epithelial-to-mesenchymal transition in metaplastic breast carcinomas with chondroid differentiation: Expression of the E-cadherin repressor snail

Applied Immunohistochemistry and Molecular Morphology

Volumn 18, Issue 6, 2010, Pages 526-531

  Gwin, Katja ^a   Buell Gutbrod, Rebecca ^a   Tretiakova, Maria ^a   Montag, Anthony ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

breast; carcinoma; chondroid differentiation; epithelial to mesenchymal transition; matrix; metaplastic; snail

Indexed keywords

TRANSCRIPTION FACTOR SNAIL; UVOMORULIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CYTOPLASM; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MASTECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; AGED; BREAST NEOPLASMS; CADHERINS; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL NUCLEUS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 78650512084     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181e8d54b     Document Type: Article

References (42)

1. Barallo-Gimeno A, Nieto MA. The snail genes as inducers of cell movement and survival: implications in development and cancer. Development. 2005;132:3151-3161.
2. Thiery J. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol. 2003;15:740-746. (Pubitemid 37487967)
3. Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 2006;66:8319-8326. (Pubitemid 44449137)
4. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol. 2005;132:3151-3161. (Pubitemid 41267170)
5. Kemler R. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet. 1993;9: 317-321. (Pubitemid 23271755)
6. Takeichi M. Cadherin cell adhesion receptor as a morphogenic regulator. Science. 1991;251:1451-1455. (Pubitemid 121000430)
7. Perez-Moreno M, Jamora C, Fuchs E. Sticky business: orchestrating cellular signals at adherens junctions. Cell. 2003;112:535-548. (Pubitemid 36263085)
8. Peinando H, Portillo F, Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol. 2004;48:365-375. (Pubitemid 39360388)
9. Thiery J, Sleeman J. Complex networks orchestrate epithelialmesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7:131-142. (Pubitemid 43278296)
10. Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2:76-83.
11. Batlle E, Sancho E, Franci C, et al. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000;2:84-89.
12. Ellis IO, Schnitt SJ, Sastre-Garau X, et al. Invasive breast carcinoma. Metaplastic carcinoma. In: Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. 1st ed. Lyon, France: IARC Press; 2003:37-41.
13. Nielson TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10:5367-5374. (Pubitemid 39100473)
14. Reis-Filho JS, Milanezi F, Steele D, et al. Metaplastic carcinomas are basal-like tumours. Histopathology. 2006;49:10-21. (Pubitemid 43972916)
15. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869-10874. (Pubitemid 32878711)
16. Sotiriou C, Neo SY, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a populationbased study. Proc Natl Acad Sci U S A. 2003;100:10393-10398. (Pubitemid 37071889)
17. Banerjee S, Reis-Filho JS, Ashley S, et al. Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol. 2006;59:729-735. (Pubitemid 44048783)
18. Gwin K, Wheeler D, Bossuyt V, et al. Breast Carcinoma with chondroid differentiation: a clinicopathologic study of 21 triple negative (ER-, PR-, Her2/neu-) cases. Int J Surg Pathol. 2010; 18:27-35.
19. Al Sayed AD, El Weshi AN, Tulbah AM, et al. Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors. Acta Oncol. 2006;45:188-195.
20. Leibl S, Moinfar F. Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors? J Clin Pathol. 2005;58:700-704. (Pubitemid 40956822)
21. Reis-Filho JS, Pinheiro C, Lambros MB, et al. EGFR amplification and lack of activating mutations in metaplastic breast carcinomas. J Pathol. 2006;209:445-453. (Pubitemid 44194559)
22. Rosen EM, Goldberg ID. Protein factors which regulate cell motility. In vitro Cell Dev Biol. 1989;25:1079-1087.
23. Lu Z, Ghosh S, Wang Z, et al. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell. 2003;4:499-515. (Pubitemid 38050046)
24. Lien HC, Hsiao YH, Lin YS, et al. Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelialmesenchymal transition. Oncogene. 2007;26:7859-7871.
25. Blechschmidt K, Sassen S, Schmalfeldt B, et al. The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients. Br J Cancer. 2008;98:489-495. (Pubitemid 351161237)
26. Dominguez D, Montserrat-Sentis B, Virgos-Soler A, et al. Phosphorylation regulates the subcellular location and activity of the snail transcriptional repressor. Mol Cell Biol. 2003;23: 5078-5089. (Pubitemid 36793351)
27. Zhou BP, Deng J, Xia W, et al. Dual regulation of Snail by GSK- 3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol. 2004;6:931-940. (Pubitemid 39359846)
28. Yang Z, Rayala S, Nguyen D, et al. Pak1 phosphorylation of snail, a master regulator of epithelial-to-mesenchyme transition modulates Snails subcellular localization and functions. Cancer Res. 2005;65: 3179-3184. (Pubitemid 40524599)
29. Ko H, Kim HS, Kim NH, et al. Nuclear localization signals of the E-cadherin transcriptional repressor Snail. Cells Tissues Organs. 2007;185:66-72. (Pubitemid 46956845)
30. Come C, Magnino F, Bibeau F, et al. Snail and slug play distinct roles during breast carcinoma progression. Clin Cancer Res. 2006;12:5395-5402. (Pubitemid 44497253)
31. Dhasarathy A, Kajita M, Wade PA. The transcription factor Snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-a. J Biol Chem. 2005;25:11740-11748. (Pubitemid 350223504)
32. Storci G, Sansone P, Trere D, et al. The basal-like breast carcinoma type is regulated by SLUG gene expression. J Pathol. 2008; 214:25-37.
33. Vega S, Morales A, Ocana OH, et al. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev. 2004;18:1131-1143. (Pubitemid 38669034)
34. Moody SE, Perez D, Pan TC, et al. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell. 2005;8: 197-209. (Pubitemid 41317591)
35. Toyama T, Zhang Z, Iwase H, et al. Low expression of the snail gene is a good prognostic factor in node-negative invasive ductal carcinomas. Jpn J Clin Oncol. 2006;36:357-363. (Pubitemid 44043924)
36. Elloul S, Elstrad MB, Nesland JM, et al. Snail, Slug, and Smad- Interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinomas. Cancer. 2005;103: 1631-1643. (Pubitemid 40490024)
37. Blanco MJ, Moreno-Bueno G, Sarrio D, et al. Correlation of Snail expression with histologic grade and lymph node status in breast carcinomas. Oncogene. 2002;21:3241-3246. (Pubitemid 34548095)
38. Prasad CP, Rath G, Mathur S, et al. Expression analysis of ECadherin, Slug and GSKb in invasive ductal carcinoma of the breast. BMC Cancer. 2009;9:325.
39. Hugo H, Ackland ML, Blick T, et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol. 2007;213:374-383. (Pubitemid 47509716)
40. Gilbert JA, Goetz MP, Reynolds CA, et al. Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy. Mol Cancer Ther. 2008;7:944-951.
41. Gwin K, Lezon-Geyda K, Harris L, et al. Chromosome 7 aneusomy in metaplastic breast carcinomas with chondroid, squamous and spindle-cell differentiation. Int J Surg Pathol. 2009; doi: 10.1177/ 1066896909334127. [Epub ahead of print]
42. Tomoda K, Kubota Y, Arata Y, et al. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J Biol Chem. 2002;277: 2302-2310. (Pubitemid 34968817)